Literature DB >> 1505610

Long-term nicotine substitution after application of a 16-hour nicotine patch in smoking cessation.

J Nørregaard1, P Tønnesen, K Simonsen, U Säwe.   

Abstract

The purpose of the study was to examine long-term nicotine substitution and its variability during use of a nicotine patch. In two smoking cessation studies a 16-h nicotine patch, releasing 15 mg nicotine, was applied daily for 16 h over 12 weeks, to 167 smokers. Salivary cotinine was highly correlated with plasma cotinine (r = 0.93), and the concentration of cotinine in a single sample in the afternoon was well correlated with the AUCcontinine over 24 h (r = 0.94). The salivary cotinine concentration after 1 week in 60 abstainers was 183 ng.ml-1. After 3,6 and 12 weeks the cotinine concentrations were 86%, 79% and 59% of the 1-week value. The degree of nicotine compensation attained by the patch after 1 week was 52% (SD 24%) in subjects who succeeded in stopping smoking for at least 3 weeks. A quarter of the subjects achieved a compensation of less than 35% of their usual nicotine intake. Nicotine substitution with this 16-h nicotine patch was stable and the risk of overcompensation was small in this group of smokers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505610     DOI: 10.1007/bf02280755

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  A modified procedure for the determination of nicotine in blood.

Authors:  S E Falkman; I E Burrows; R A Lundgren; B F Page
Journal:  Analyst       Date:  1975-02       Impact factor: 4.616

2.  Puffing topography as a determinant of smoke exposure.

Authors:  R B Bridges; J G Combs; J W Humble; J A Turbek; S R Rehm; N J Haley
Journal:  Pharmacol Biochem Behav       Date:  1990-09       Impact factor: 3.533

Review 3.  Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

Authors:  K O Fagerstrom; N G Schneider
Journal:  J Behav Med       Date:  1989-04

4.  Transdermal nicotine facilitates smoking cessation.

Authors:  J E Rose; E D Levin; F M Behm; C Adivi; C Schur
Journal:  Clin Pharmacol Ther       Date:  1990-03       Impact factor: 6.875

5.  Clinical and pharmacokinetic properties of a transdermal nicotine patch.

Authors:  S C Mulligan; J G Masterson; J G Devane; J G Kelly
Journal:  Clin Pharmacol Ther       Date:  1990-03       Impact factor: 6.875

6.  Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems.

Authors:  J P Dubois; A Sioufi; P Müller; D Mauli; P R Imhof
Journal:  Methods Find Exp Clin Pharmacol       Date:  1989-03

7.  A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation.

Authors:  P Tønnesen; J Nørregaard; K Simonsen; U Säwe
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

8.  Combination of behavioral smoking cessation with transdermal nicotine substitution.

Authors:  G Buchkremer; H Bents; M Horstmann; K Opitz; R Tölle
Journal:  Addict Behav       Date:  1989       Impact factor: 3.913

9.  Two and four mg nicotine chewing gum and group counselling in smoking cessation: an open, randomized, controlled trial with a 22 month follow-up.

Authors:  P Tønnesen; V Fryd; M Hansen; J Helsted; A B Gunnersen; H Forchammer; M Stockner
Journal:  Addict Behav       Date:  1988       Impact factor: 3.913

10.  Nicotine concentrations in urine and saliva of smokers and non-smokers.

Authors:  C Feyerabend; T Higenbottam; M A Russell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-03
View more
  5 in total

1.  Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.

Authors:  Jessica Grundey; Rosa Amu; Géza Gergely Ambrus; Georgi Batsikadze; Walter Paulus; Michael A Nitsche
Journal:  Psychopharmacology (Berl)       Date:  2015-02-27       Impact factor: 4.530

2.  Nicotine modulates human brain plasticity via calcium-dependent mechanisms.

Authors:  Jessica Grundey; Jerick Barlay; Giorgi Batsikadze; Min-Fang Kuo; Walter Paulus; Michael Nitsche
Journal:  J Physiol       Date:  2018-10-17       Impact factor: 5.182

3.  Oral fluid nicotine markers to assess smoking status and recency of use.

Authors:  Karl B Scheidweiler; Gina F Marrone; Diaa M Shakleya; Edward G Singleton; Stephen J Heishman; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-10       Impact factor: 3.681

4.  Nicotinergic impact on focal and non-focal neuroplasticity induced by non-invasive brain stimulation in non-smoking humans.

Authors:  Nivethida Thirugnanasambandam; Jessica Grundey; Kim Adam; Anne Drees; Angela C Skwirba; Nicolas Lang; Walter Paulus; Michael A Nitsche
Journal:  Neuropsychopharmacology       Date:  2010-12-15       Impact factor: 7.853

5.  Nicotinic Restoration of Excitatory Neuroplasticity Is Linked to Improved Implicit Motor Learning Skills in Deprived Smokers.

Authors:  Jessica Grundey; Nivethida Thirugnasambandam; Rosa Amu; Walter Paulus; Michael A Nitsche
Journal:  Front Neurol       Date:  2018-05-28       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.